-
-
The latest news from the womens health initiative (WHI) includes 3 noteworthy reports: the news release announcing the cancellation of the estrogen-only arm of the clinical trial,1 a comparison of the participants in the 2 clinical trial arms(estrogen-progestin and estrogen-only),2 and the updated, adjudicated lorectal cancer results from the estrogen-progestin arm.3
-
-
his retrospective review summarizes the clinical outcome and safety among 141 patients who were treated with boric acid and flucytosine for culture-proven Candida glabrata. These data were collected at both Wayne State University School of Medicine and Ben Gurion University.
-
A national group of 13 experts participated in a consensus conference sponsored by The Endocrine Society to evaluate the literature on subclinical thyroid disease in order to address the question of treatment. This effort was stimulated by the obvious differences in conclusions and recommendations regarding this clinical problem in the medical literature.
-
I review for and subscribe to a journal, Fetal Diagnosis & Therapy, that services predominantly subspecialists in prenatal diagnosis. For example, recently there were 3 wonderful papers on in utero stem cell transplantation.
-
A retrospective study of 396 patients undergoing laparoscopic management for a 7-year period at a single institution was performed. Complications were statistically more likely if hysterectomy was also being performed or if the mass was of a smaller size.
-
Positive Alendronate Data in Osteoporosis; NSAIDs For Myocardial Infarction; Four-Hour Window for CAP Patients; FDA Actions.
-
In this special feature, up-to-date information will be provided regarding the risks and benefits of various diagnostic methods available today for patients of advanced maternal age (AMA).
-
Women who initially were diagnosed with Stage IA disease and who had serous borderline tumors or underwent cystectomy appeared to derive the most benefit from restaging surgery. Nonetheless, the indications for restaging surgery remain controversial, as no difference in recurrence rate was observed between women who underwent restaging and those who did not.
